News & Perspective

Jan 28, 2011

Jan 28, 2011

Experts air kinks in antiviral use during H1N1 pandemic

(CIDRAP News) – Although antiviral drugs were used to treat many seriously sick people during the H1N1 influenza pandemic, experts at a conference today said they could have been used more widely and that some opportunities to learn from their use were missed.

Apr 26, 2010

Apr 26, 2010

H1N1 LESSONS LEARNED Vaccine production foiled, confirmed experts' predictions

Second in a series marking the 1-year anniversary of novel H1N1 pandemic influenza. The first, on the virus itself, appeared Apr 23.

Dec 17, 2009

Dec 17, 2009

Vaccine availability opens up as doses approach 100 million

(CIDRAP News) – The nation is reaching a new milestone in its fight against pandemic flu, with the number of vaccine doses expected to reach 100 million by the end of the week and nearly half of states opening up immunization to anyone who wants it, federal officials said today.

Nov 24, 2009

Nov 24, 2009

Novartis unveils US cell-based flu vaccine plant

(CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.

Nov 04, 2009

Nov 04, 2009

CDC says vaccine shortage likely to outlast current H1N1 wave

(CIDRAP News) – The head of the Centers for Disease Control and Prevention (CDC) predicted today that the current wave of H1N1 influenza is likely to begin to wane before the shortage of vaccine for it eases.

Dr. Thomas Frieden made the comment at a wide-ranging US House subcommittee session that aired the reasons for and impact of the vaccine delays and the prospects for avoiding a repeat of the problem. The session was streamed over the Web.

Nov 02, 2009

Nov 02, 2009

Studies reaffirm 2 vaccine doses in kids, show safety in pregnant women

(CIDRAP News) – Interim clinical trial findings announced today affirm that children younger than 10 need two pandemic H1N1 vaccine doses, and initial findings in pregnant women reveal no safety concerns and a need for only one dose.

Federal officials also detailed the role of an independent panel of experts to review vaccine safety data and released a report outlining the government's vaccine safety monitoring system.

Sep 03, 2009

Sep 03, 2009

Feds engage media on pandemic vaccine communication

(CIDRAP News) – In advance of the expected pandemic H1N1 vaccination campaign this fall, the US Department of Health and Human Services (HHS) yesterday invited the media to join federal officials in a tabletop exercise to prepare for some possible communications challenges.

Aug 21, 2009

Aug 21, 2009

First H1N1 vaccine trial data expected in mid-September

(CIDRAP News) – Federal health officials today said the first results of novel H1N1 vaccine trials—needed for determining the number and size of doses people will get—are expected in mid-September.

Two trials in adult and elderly volunteers started Aug 7 and are now almost fully enrolled, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), at a press teleconference.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»